Skip to content

Airways symptoms of exposure to cold air

A qualitative study of airways symptoms of experimental exposure to cold air

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13484593
Enrollment
100
Registered
2017-04-19
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis, asthma, COPD Respiratory Allergic rhinitis, asthma, COPD

Interventions

Participants undergo a ramped maximum exercise test on a motorised treadmill to predict their maximum oxygen consumption (VO2max). Participants are allocated to one of five groups based on their diagn

Sponsors

Umeå University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy group: 1. Non-smokers 2. No allergy or respiratory disease 3. Not on medication 4. Aged 18 and older Allergic rhinitis group: 1. Non-smokers 2. Symptoms of allergy to common airborne allergens 3. Positive skin prick test 4. Aged 18 and older Asthma group: 1. Non-smoker 2. Physician-diagnosed asthma (stable) 3. Regular use of asthma medications in the past three months 4. Aged 18 and older COPD group: 1. Physician diagnosed COPD 2. Current or former smoker (at least ten pack years) 3. FEV1/FVC 400 training hours/year 3. No allergy or asthma 4. Aged 18 and older 5. Non-smokers

Exclusion criteria

Exclusion criteria: Recent airway infection

Design outcomes

Primary

MeasureTime frame
General and airways symptoms are recorded by focused open interviews (symptom intensity is measured using the Borg CR10 scale) at session one, two and three.

Secondary

MeasureTime frame
Group comparison of airway symptoms are measured using focused open interviews using the Borg CR10 scale at session one, two and three.

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026